Clinical Trial

Combined Anabolic Therapy

Study acronym: CAT
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this research study the study investigators want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-08-14; most recent amendment 2026-04-14.
Status change: Not Yet Recruiting → Recruiting 2025-03-13
Trial Details
NCT Number NCT06558188
Lead Sponsor Massachusetts General Hospital
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Osteoporosis, Postmenopausal, Osteoporosis
Enrollment 50 participants
Start Date 2025-02-03
Primary Completion 2027-12-30 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-17